News and Updates

Arrowhead Pharmaceuticals gears up for the ESC Congress to unveil critical clinical data on its latest RNAi cardiovascular therapies. Read the latest.

Discover how AUTOMA+ 2026 is leveraging AI and data intelligence to revolutionize clinical trial efficiency and speed up drug development timelines.

Akeso has received NMPA clearance to begin clinical trials for AK157D1, a B7-H3 targeting ADC designed to advance precision oncology for solid tumors.

Orum Therapeutics moves to Phase 1 trials for ORM-1153 after FDA clearance. Learn about this targeted protein degrader and its role in cancer research.

A cancer survivor cycles 186 miles to thank the medical team behind her lifesaving clinical trial. Discover the impact of experimental cancer research.

Explore how the Merck and SCRI partnership is revolutionizing clinical trial operations by bringing high-level cancer research into local communities.

Can psilocybin-assisted therapy transition from lab success to routine care? Explore the clinical, regulatory, and practical challenges ahead.

Isofol Medical expands its Phase Ib/II study of arfolitixorin to boost patient enrollment in trials for metastatic colorectal cancer treatments.

New research suggests health improvements occur independent of weight loss. Discover why metabolic markers matter more than the scale for your health.

Discover how AI and point-of-care diagnostics are streamlining clinical trials, boosting patient recruitment, and accelerating medical breakthroughs.